跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
百泌达 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Exenatide Injection
Approved
化学药品
Exenatide Injection
ASTRAZENECA AB
🇨🇳 National Medical Products Administration
Approval Date
Jun 14, 2023
Approval ID
8TELauAcrcD
Company
ASTRAZENECA AB
Type
化学药品
Approval Details
Approval Id
8TELauAcrcD
Approval Number
国药准字HJ20140822
Generic Name
艾塞那肽注射液
Generic Name En
Exenatide Injection
Trade Name
百泌达
Drug Type
化学药品
Dosage Form
注射剂
Strength
10μg(0.25mg/ml,2.4ml/支)
Reg Date
2023-06-14
Expired Date
2028-06-13
Company Name
ASTRAZENECA AB
Production Company Name
BAXTER PHARMACEUTICAL SOLUTIONS LLC
Company Detail Path
/organization/astrazeneca-ab
Production Company Detail Path
/organization/baxter-pharmaceutical-solutions-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 14, 2023
Approval ID
8TELauAcrcD
Type
化学药品
Back to NMPA Approvals